-PTI NEEMRANA (RAJASTHAN): Indian biotechnology sector is looking to be a $100 billion sector by 2025, Biocon chief Kiran Mazumdar-Shaw said here on Saturday. "We want to make Indian biotechnology a $100 billion sector by 2025. I really believe this can be done if we have right policies in place, right resources and right investments," Biocon chairman and managing director Kiran Mazumdar-Shaw told PTI. She was speaking on the sidelines of the third...
More »SEARCH RESULT
Total Matching Records found : 181
No Anganwadi for homeless-Yoshita Sengupta
-DNA An allocation of Rs 17,700 crore in the 2013-2014 Union Budget but not a single accountable rupee spent for pre-school education or a plate of food for the homeless children in Mumbai. Yoshita Sengupta investigates the absence of homeless children from ICDS registers Mumbai: In 2010, Ms. Rekha, a homeless woman living on the footpath in Mumbai in her last month of pregnancy, slipped while trying to cross a wall. She...
More »New drug policy forces many pharmacies to shut shop -Raji Reddy Kesireddy
-The Economic Times HYDERABAD: Numerous pharmacies - especially those operating on rented space - are shutting down across the country, hurt by a sharp decline in margins after the introduction of a new pricing policy for medicines and intense competition from bigger players. The new Drug Price Control Order (DPCO), which was notified on May 15, has made the prices of some 150 drugs fall steeply. Under this, companies and retailers are...
More »Ranbaxy drugs fine, say WHO and UK regulator -Rema Nagarajan
-The Times of India NEW DELHI: In yet another twist to the Ranbaxy scandal, the drug regulatory authority of the UK government has issued a statement clarifying that they have found no evidence of any Ranbaxy product in the UK market having been "of unacceptable quality". Last month, WHO had issued a similar statement. It had said that there was no evidence of any of the Ranbaxy products being of unacceptable...
More »Govt bans popular diabetes drug and analgin -Rupali Mukherjee
-The Times of India MUMBAI: The government has banned three popular medicines-the widely prescribed anti-diabetes drug pioglitazone, painkiller analgin and anti-depressant deanxit-in the wake of health risks associated with them. While it's believed that pioglitazone can cause heart failure and increases the risk of bladder cancer, analgin has been discarded the world over on grounds of patient safety. Deanxit, on the other hand is a harmful combination, which has been long...
More »
